跳至主要内容
临床试验/PACTR202202814392581
PACTR202202814392581尚未招募未知

ROLE OF VITAMIN D3 IN THE MANAGEMENT OF SICKLE CELL DISEASE (SCD): A RANDOMIZED-CONTROLLED TRIAL OF PATIENTS IN LAGOS STATE, NIGERIA

Brain and Body Foundation0 个研究点目标入组 300 人开始时间: 2021年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Month(s) 至 23 Month(s)(—)
性别
All

入选标准

  • Age: Patients between 1 year and 12 years
  • Gives informed consent to participate
  • Sickle cell disease, confirmed by laboratory tests

排除标准

  • Age: < 1 year and > 12years
  • Consume more than 1000 IU per day of vitamin D from all supplemental sources combined (individual vitamin D supplements, calcium plus vitamin D supplements, medications with vitamin D, and multivitamins) in the past 4 weeks.
  • Unable to complete questionnaires or adhere to study requirements
  • Presence of complications like leg ulcers, strokes, and avascular necrosis of the head of the femur

研究者

发起方
Brain and Body Foundation

相似试验